Public source
Reviewed 2 Oct 2026
Completeness Fair (36%)
Eyonis LCS
Median TechnologiesEyonis LCS is software that analyses low-dose chest CT examinations in lung cancer screening. It detects and localises pulmonary nodules and assigns each nodule a malignancy risk score. Results are provided in a DICOM report that lists nodules by score, categorised as probably benign, suspicious or very suspicious, with measurements of diameter and volume. The software is intended for use by radiologists.
No papers to support — we monitor for new evidence.
General Information
Product name
Company
Modality
Main task
Subspeciality
Disease targeted
Regulatory Information
Pathway:
MDR
Class:
Class IIb
Verified by Health AI Register
Verified by Health AI Register
Other certifications
Not specified
Evidence & Research
No research papers or evidence on file yet.
The registry monitors publications for new evidence.
Technical Specifications
Patient population age
Not specified
Input
Not specified
Input format
Not specified
Output
Not specified
Output format
Not specified
Integration
Not specified
Deployment
Not specified
Trigger for analysis
Not specified
Processing time
Not specified
Population
Market Presence
On market since
Not specified
AI Platforms
Resellers
Not specified
Countries present
Not specified
Paying clinical customers
Not specified
Research/test users
Not specified
Pricing Information
Pricing model
Not specified
Based on
Not specified
Source: Public | First published: Oct 2, 2026 | Last updated: Oct 2, 2026